The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease

Published:2018-04-26 Issue:6 Volume:24 Page:1344-1351
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Chi Lisa Yue¹²,Zitomersky Naamah Levy¹²,Liu Enju¹³,Tollefson Sophia¹²,Bender-Stern Julia¹²,Naik Snehal⁴,Snapper Scott¹²⁵,Bousvaros Athos¹²

Affiliation:

1. Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Boston Children’s Hospital, Boston, Massachusetts

2. Harvard Medical School, Boston, Massachusetts

3. Institutional Centers for Clinical and Translational Research, Boston Children’s Hospital, Boston, Massachusetts

4. Prometheus Laboratories Inc., San Diego, California 92121

5. Division of Gastroenterology, Brigham and Women’s Hospital, Boston, Massachusetts, USA

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/24/6/1344/24831302/izy010.pdf

Reference26 articles.

1. A 10-year, single tertiary care center experience on the durability of infliximab in pediatric inflammatory bowel disease;Vahabnezhad;Inflamm Bowel Dis,2014

2. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

3. Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension;Hyams;Curr Med Res Opin,2011

4. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease;Baert;N Engl J Med,2003

5. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease;Hanauer;Clin Gastroenterol Hepatol,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2023-12-27

2. Effectiveness of strategies to suppress antibodies to infliximab in pediatric inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2023-12-05

3. Prediction of Prognosis in Pancreatic Cancer According to Methionyl-tRNA Synthetase 1 Expression as Determined by Immunohistochemical Staining;Cancers;2023-11-14

4. Dose escalation of adalimumab as a strategy to overcome anti-drug antibodies: A case report of infantile-onset inflammatory bowel disease;World Journal of Gastroenterology;2023-10-14

5. Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn’s Disease: A Pilot Study;Biomedicines;2023-09-19